Skip to main content

PT-141 Efficacy

Meaning

The demonstrated capacity of the synthetic peptide PT-141 (Bremelanotide) to produce a desired therapeutic effect, specifically the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women and erectile dysfunction in men. Efficacy is measured by clinical trials assessing objective and subjective improvements in sexual desire and function. The peptide represents a novel, central-acting approach to sexual dysfunction.